Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.
Ncardia has raised $60.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2021.
Ncardia's investors include InnovationQuarter, Vesalius Biocapital Partners, EISMEA, S.R.I.W., Sambrinvest.
Ncardia is headquartered in Leiden, The Netherlands.
Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.
Ncardia is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ncardia — Funding & Investors." VCBacked, November 16, 2021, https://www.vcbacked.co/company/ncardia. Accessed November 13, 2026.
VCBacked. (2021). Ncardia — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/ncardia
{{cite web |title=Ncardia — Funding & Investors |url=https://www.vcbacked.co/company/ncardia |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Ncardia? Request a listing update